Phathom Pharmaceuticals, Inc. (PHAT)
6.92
-0.16
(-2.26%)
USD |
NASDAQ |
Oct 02, 16:00
6.85
-0.07
(-1.01%)
Pre-Market: 08:58
Phathom Pharmaceuticals Net Income (Quarterly) : -17.58M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.58M |
| March 31, 2026 | -30.37M |
| December 31, 2025 | -21.15M |
| September 30, 2025 | -29.97M |
| June 30, 2025 | -75.81M |
| March 31, 2025 | -94.32M |
| December 31, 2024 | -74.45M |
| September 30, 2024 | -85.58M |
| June 30, 2024 | -91.45M |
| March 31, 2024 | -82.85M |
| December 31, 2023 | -79.57M |
| September 30, 2023 | -43.24M |
| June 30, 2023 | -40.96M |
| March 31, 2023 | -37.81M |
| December 31, 2022 | -55.05M |
| Date | Value |
|---|---|
| September 30, 2022 | -51.09M |
| June 30, 2022 | -50.92M |
| March 31, 2022 | -40.66M |
| December 31, 2021 | -35.83M |
| September 30, 2021 | -36.66M |
| June 30, 2021 | -36.55M |
| March 31, 2021 | -34.84M |
| December 31, 2020 | -53.72M |
| September 30, 2020 | -34.10M |
| June 30, 2020 | -21.10M |
| March 31, 2020 | -20.14M |
| December 31, 2019 | -98.01M |
| September 30, 2019 | -68.11M |
| December 31, 2018 | -0.484M |
| September 30, 2018 | -0.29M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 74.27M |
| Total Expenses (Quarterly) | 91.86M |
| EPS Diluted (Quarterly) | -0.2099 |
| Enterprise Value | 923.63M |
| Gross Profit Margin (Quarterly) | 79.68% |
| Profit Margin (Quarterly) | -23.67% |
| Earnings Yield | -18.42% |
| Normalized Earnings Yield | -18.42 |